Article

Short report: occurrence of Leishmania donovani DNA in donated blood from seroreactive Brazilian blood donors.

Instituto de Microbiologia Professor Paulo de Góes and Hospital Universitário-Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
The American journal of tropical medicine and hygiene (Impact Factor: 2.74). 01/2000; 62(1):128-31.
Source: PubMed

ABSTRACT Human visceral leishmaniasis (kala-azar) transmitted by blood transfusion has been described in previous reports. Seroprevalence of antibodies to Leishmania donovani was shown to be related to prior blood transfusions in multiply transfused hemodialysis patients in Natal, Rio Grande do Norte, Brazil. In this study, a possible correlation between seroreactivity and the presence of L. donovani DNA was investigated in asymptomatic healthy blood donors. Sera were tested using the fucose mannose ligand (FML) ELISA, which was shown to have a sensitivity of 100%, a specificity of 96-100%, reliability, and diagnostic and prognostic potential for the detection of human and canine kala-azar, respectively. Leishmanial DNA was assessed by the polymerase chain reaction (PCR) and dot-blot hybridization techniques in blood and bone marrow samples. Among 21 FML-seroreactive asymptomatic blood donors, 5 (24%) were positive by the PCR and 9 (43%) were positive in a dot-blot assay of blood samples, showing a significant correlation (chi2 = 14.24, P < 0.01). No Leishmania DNA was detected in 20 FML non-reactive blood donors. Our results point to the need for control of transmission of kala-azar by blood transfusion in areas endemic for this disease.

1 Follower
 · 
105 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Introduction: Visceral leishmaniasis (VL) is a public health problem in Bangladesh with the highest burden in the Mymensingh district. The disease is transmitted by a sand fly bite, but it could also be transmitted through blood transfusion. No information is available about the prevalence of Leishmania infection among blood donors in Bangladesh. Objective: To determine the prevalence of Leishmania donovani (LD) among the blood donors in a kala-azar endemic district of Bangladesh. Methods: A total of 1195 voluntary blood donors in the Blood Transfusion Department, Mymensingh Medical College Hospital, Mymensingh from August, 2010 to April, 2011 were enrolled into the cross-sectional study. After obtaining written consent, the socio-demographic data and past history of illness was collected. The laboratory technician performed the rK-39 strip test using two drops of finger pricked blood and if the test was positive, then 3.0 ml of venous blood was drew for polymerase chain reaction (PCR) analysis. Results: The mean age of blood donors was 27 (SD, 7.95) years and 82.4% of them were male. The majority of the donors were literate and had a better socieconomic condition reflected by better household condition. Only 2.6 % had a family memeber with VL in the past. Three blood donors were positive for leishmania infection by rK39 strip test (0.3 %, 95%CI, 0.05-0.73). None of these 3 had active leishmania infection as demonstrated by PCR. During six months follow up, neither rK39 positive (N=3) or rK39 negative (N=1192) donors developed VL. Conclusion: The risk of LD transmission by blood transfusion is very low. Therefore the chance for transmission of VL through blood transfusion is negligible. We believe that the National VL Elimination Program does not need set up a routine screening for LD infection in the blood transfusion centre, located in the VL endemic areas of Bangladesh.
    National Public Health Conference, 2013, Dhaka, Bangladesh; 01/2013
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: After HIV epidemic several countries reported co-infections of Leishmania with HIV. The co-infection of these two pathogens results into rapid disease progression, more severe disease and poor response to treatment. A systematic review of literature from India is presented here. On reviewing the literature since first case of visceral leishmaniasis (VL) and HIV was published from India in 1999, a number of cases of HIV-leishmania co-infections have been reported, but the proportion has been low (0.029-0.4%) as reported to other countries where both these diseases are co-endemic. So far, more than 89 cases of VL-HIV and 10 cases of cutaneous leishmaniasis (CL) with HIV have been published since 1999. Of these 10 cases, 5 had simple CL and 5 cases manifested with diffuse cutaneous leishmaniasis (DCL). In addition, one case of post-kala-azar mucocutaneous leishmaniasis (PKML) in a full blown AIDS patient has also been reported. In two cases no clear description could be ascertained whether these were cases of DCL or post-kala-azar dermal leishmaniasis (PKDL). Though the first case of VL-HIV co-infection was reported from sub-Himalayan state of Uttarakhand, most cases are reported from VL endemic state of Bihar. HIV-Leishmania is not alarmingly high in India. Most cases occurred during 1997-2007. After that the number of new cases has gone down. Most probably due to low HIV prevalence in VL and CL endemic regions and free supply of highly active anti-retroviral therapy (HAART) for HIV infected patients.
    International Journal of Infectious Diseases 10/2014; DOI:10.1016/j.ijid.2014.07.011 · 2.33 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Leishmaniasis is a clinically heterogeneous syndrome caused by intracellular protozoan parasites of the genus Leishmania. The clinical spectrum of leishmaniasis encompasses subclinical (not apparent), localized (skin lesion), and disseminated (cutaneous, mucocutaneous, and visceral) infection. This spectrum of manifestations depends on the immune status of the host, on the parasite, and on immunoinflammatory responses. Visceral leishmaniasis causes high morbidity and mortality in the developing world. Reliable laboratory methods become mandatory for accurate diagnosis, especially in immunocompromised patients such as those infected with HIV. In this article, we review the current state of the diagnostic tools for leishmaniasis, especially the serological test.
    The Journal of Infection in Developing Countries 08/2014; 8(8):961-72. DOI:10.3855/jidc.4310 · 1.27 Impact Factor

Full-text (2 Sources)

Download
78 Downloads
Available from
May 17, 2014